Slide 1IAPCOI dec-2011 TDAP Slide 2 Recommendations for changes in and additional uses of Tdap: There is no minimum interval required or advised between receipt of a tetanus…

Slide 1The GSK Virtual Library From The Trenches presented by Robert Guerrero SLA Pharmaceutical & Health Technology Spring Meeting April 5, 2005 Slide 2 GSK and Information…

Slide 1Putting the Tensor back in Tensor-Based Morphometry Ged Ridgway 1, Sebastien Ourselin 1, Brandon Whitcher 2, Derek Hill 1 and Nick Fox 3 1.Centre for Medical Image…

Slide 1LLC «Severstal-Gonvarri-Kaluga» Slide 2 SEVERSTAL–GONVARRI–KALUGA PLANNING First cut 23.06 First cut 18.10 First pack 19.07 Slide 3 GENERAL INFORMATION Start…

Slide 1Case studies: Identifying the treatment uncertainties of people with asthma & their clinicians Colin Gelder Asthma Editor DUETs Slide 2 Conflicts of Interest Educational…

Slide 1The role of chromatography in physico-chemical characterisation Shenaz Nunhuck CASS, GSK Slide 2 Why do we need physchem measurements?  Physicochemical properties…

Slide 1 Linking Large Datasets Why, How, and What Not To Do Bradley G Hammill Duke Clinical Research Institute Slide 2 Presenter disclosure information Bradley G Hammill…

Slide 1 The Innovative Medicines Initiative Intellectual Property Policy March 20 th, 2006 Slide 2 Ulf Petrusson Professor of Law Director CIP Boo Edgar Dr Med Sci (Clin…

Slide 1 Enhancing the drug discovery pipeline – a perspective on CV drugs Patrick Vallance Head of Drug Discovery, GSK Slide 2 Scientific publications in biomedicine A…

Slide 1 Prevention and potential intervention in persistent hepatitis B virus infection using a Pre-S/S vaccine Daniel Shouval Liver Unit Hadassah-Hebrew University Hospital…